Alvino Mark 4

What Happened
Mark Alvino, a director of Abeona Therapeutics, sold 13,500 shares of ABEO in an open-market disposal on January 21, 2026. The reported weighted-average sale price was $5.23 per share, generating gross proceeds of $70,574. This was a sale (S) transaction, which retail investors typically view as routine insider selling rather than a direct bullish signal.

Key Details

• Transaction date: 2026-01-21 (filed same day). Filing appears timely.
• Trade: Open-market sale of 13,500 shares at a weighted average price of $5.23; total proceeds $70,574.
• Price range: Shares were sold in multiple trades at prices between $5.21 and $5.235; weighted average reported (see footnote).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: The reporting person offers to provide, on request, full breakdown of number of shares sold at each separate price within the stated range. No 10b5-1 plan, tax withholding, gift notation, or option exercise was indicated.

Context
Sales by directors can reflect many reasons (diversification, personal liquidity, pre-planned transactions). This single open-market sale does not, by itself, indicate company performance or insider conviction. Retail investors should consider this alongside other insider activity, company fundamentals, and recent news.